{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:20:19Z","timestamp":1781497219525,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["IFR170125217588"],"award-info":[{"award-number":["IFR170125217588"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["CSUR160414162143"],"award-info":[{"award-number":["CSUR160414162143"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004513","name":"Harry Crossley Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001325","name":"Cancer Association of South Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"South African Rooibos Council"},{"DOI":"10.13039\/501100004477","name":"Stellenbosch University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004477","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jchromb.2018.02.023","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T02:15:24Z","timestamp":1519092924000},"page":"71-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["A high-throughput UPC2-MS\/MS method for the separation and quantification of C19 and C21 steroids and their C11-oxy steroid metabolites in the classical, alternative, backdoor and 11OHA4 steroid pathways"],"prefix":"10.1016","volume":"1080","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3533-0590","authenticated-orcid":false,"given":"Therina","family":"du Toit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Stander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2018.02.023_bb0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jchromb.2005.05.037","article-title":"Improving LC\u2013MS sensitivity through increases in chromatographic performance: comparisons of UPLC\u2013ES\/MS\/MS to HPLC\u2013ES\/MS\/MS","volume":"825","author":"Churchwell","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2018.02.023_bb0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jsbmb.2010.05.001","article-title":"Advantages and challenges of mass spectrometry assays for steroid hormones","volume":"121","author":"Stanczyk","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0015","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.4155\/bio.11.254","article-title":"Challenges and benefits of endogenous steroid analysis by LC-MS\/MS","volume":"3","author":"Couchman","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2018.02.023_bb0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchromb.2016.07.024","article-title":"High-throughput analysis of 19 endogenous androgenic steroids by ultra-performance convergence chromatography tandem mass spectrometry","volume":"1031","author":"Quanson","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2018.02.023_bb0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.beem.2008.01.008","article-title":"Androgen biosynthetic pathways in the human prostate","volume":"22","author":"Luu-The","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0030","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tem.2004.09.004","article-title":"The backdoor pathway to dihydrotestosterone","volume":"15","author":"Auchus","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0035","doi-asserted-by":"crossref","first-page":"E367","DOI":"10.1210\/jc.2011-1997","article-title":"Increased activation of the alternative \u201cbackdoor\u201d pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis","volume":"97","author":"Kamrath","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-4731(84)90382-0","article-title":"Development of plasma 21-deoxycortisol radioimmunoassay and application to the diagnosis of patients with 21-hydroxylase deficiency","volume":"21","author":"Milewicz","year":"1984","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0045","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0022-4731(89)90426-3","article-title":"Radioimmunoassay of plasma 21-deoxycortisol","volume":"33","author":"Nahoul","year":"1989","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2013.07.006","article-title":"11\u03b2-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: a putative role in castration resistant prostate cancer?","volume":"377","author":"Storbeck","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jsbmb.2013.04.010","article-title":"11\u03b2-Hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5\u03b1-reductase yielding 11\u03b2-hydroxy-5\u03b1-androstanedione","volume":"138","author":"Swart","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0060","doi-asserted-by":"crossref","first-page":"13228","DOI":"10.3390\/molecules181113228","article-title":"11\u03b2-Hydroxyandrostenedione returns to the steroid arena: biosynthesis, metabolism and function","volume":"18","author":"Bloem","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2018.02.023_bb0065","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mce.2014.12.009","article-title":"11\u03b2-Hydroxyandrostenedione: downstream metabolism by 11\u03b2HSD, 17\u03b2HSD and SRD5A produces novel substrates in familiar pathways","volume":"408","author":"Swart","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0070","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2012-2912","article-title":"Liquid chromatography \u2013 tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation","volume":"98","author":"Rege","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2017.07.034","article-title":"Adrenal C11-oxy C21 steroids contribute to the C11-oxy C19 steroid pool via the backdoor pathway in the biosynthesis and metabolism of 21-deoxycortisol and 21-deoxycortisone","author":"Barnard","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0080","article-title":"The in vitro metabolism of 11\u03b2-hydroxyprogesterone and 11-ketoprogesterone to 11-ketodihydrotestosterone in the backdoor pathway","author":"Van Rooyen","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0085","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O'Reilly","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0090","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-15-1181","article-title":"Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency","volume":"174","author":"Turcu","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jsbmb.2011.11.003","article-title":"The influence of Aspalathus linearis (Rooibos) and dihydrochalcones on adrenal steroidogenesis: quantification of steroid intermediated and end products in H295R cells","volume":"128","author":"Schloms","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0100","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/jc.2015-1023","article-title":"Profiles of 21-carbon steroids in 21-hydroxylase deficiency","volume":"100","author":"Turcu","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0105","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1210\/jc.2016-3989","article-title":"11-Oxygenated androgens are biomarkers of adrenal volume and testicular adrenal rest tumors in 21-hydroxylase deficiency","volume":"102","author":"Turcu","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsbmb.2016.06.009","article-title":"Profiling adrenal 11\u03b2-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC2-MS\/MS quantification of 11\u03b2-hydroxytestosterone, 11keto-testosterone and 11keto-dihydrotestosterone","volume":"166","author":"Du Toit","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.mce.2017.09.026","article-title":"Inefficient UGT-conjugation of adrenal 11\u03b2-hydroxyandrostenedione metabolites highlights C11-oxy C19 steroids as the predominant androgens in prostate cancer","volume":"461","author":"Du Toit","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clinbiochem.2004.11.007","article-title":"Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry","volume":"38","author":"Taylor","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.forsciint.2006.05.021","article-title":"Validation of new methods","volume":"165","author":"Peters","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0130","first-page":"98","article-title":"Progesterone 16\u03b1-hydroxylase activity is catalyzed by human cytochrome P450 17\u03b1-hydroxylase","volume":"771","author":"Swart","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2018.02.023_bb0135","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jsbmb.2015.07.024","article-title":"Estimation of reference curves for the urinary steroid metabolome in the first year of life in healthy children: tracing the complexity of human postnatal steroidogenesis","volume":"154","author":"Dhayat","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217317646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217317646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T09:12:46Z","timestamp":1603876366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023217317646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":27,"alternative-id":["S1570023217317646"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.02.023","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A high-throughput UPC2-MS\/MS method for the separation and quantification of C19 and C21 steroids and their C11-oxy steroid metabolites in the classical, alternative, backdoor and 11OHA4 steroid pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}